I am looking at this stock. Also hold Cann group. But from a consumer Viewpoint, having just commenced treatment with CBD oil, I found them good to deal with. Cannabis researcher honahlee.com.au rates all the clinics and Emyria is the only one doing research on their patients. Only downside is the IT system is not too efficient.
